Top Institute Pharma   Report issue

Foundation Phase 1
Founded: Leiden Netherlands (2006)

Organization Overview

First Clinical Trial
2015
NCT02821494
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

hespecta (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Precancerous Conditions (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1